Jianzhi Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jianzhi Sun has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Biao Wu
National Engineering Laboratory of Biohydrometallurgy General Research Institute for Nonferrous Metals 100088 Beijing China
1 shared publication - Chunhui Li
Materials Science Division
1 shared publication Chunyan Kong
College of Chemistry and Chemical Engineering, Dezhou University, Shandong Dezhou, 253023, P. R. China
1 shared publicationDan-Dan Yang
Department of Hematology, Qilu Hospital, Shandong University, Jinan, China
1 shared publication- Dong Yan
College of Chemistry and Chemical Engineering, Dezhou University, Shandong Dezhou, 253023, P. R. China
1 shared publication - Feng Qi
Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
1 shared publication
Latest Publications
- Open Access
- 30 June 2021
- Published by Journal of New Materials for Electrochemical Systems in Journal of New Materials for Electrochemical Systems
- Vol. 24 (2) , 73-77
Molybdenum Trioxide Microrods synthesized with Corn Straw as Biological Templates and its Electrochemical Performance in Aqueous Battery
- 30 June 2021
- Published by Journal of New Materials for Electrochemical Systems in Journal of New Materials for Electrochemical Systems
- Vol. 24 (2) , 73-77
Open AccessMolybdenum Trioxide Microrods synthesized with Corn Straw as Biological Templates and its Electrochemical Performance in Aqueous Battery
- Open Access
Mechanism for the Bio-Oxidation and Decomposition of Pentlandite: Implication for Nickel Bioleaching at Elevated pH
This work investigated the effects of Fe3+, H+ and adsorbed leaching bacteria on the bioleaching of pentlandite. Collectively, an integrated model for the oxidation and decomposition of pentlandite was built to describe the behaviors of different components in a bioleaching system. Proton ions and ferric ions could promote the break and oxidation of Ni-S and Fe-S bonds. The iron-oxidizing microorganisms could regenerate ferric ions and maintain a high Eh value. The sulfur-oxidizing microorganisms showed significant importance in the oxidation of polysulfide and elemental sulfur. The atoms in pentlandite show different modification pathways during the bioleaching process: iron transformed through a (Ni,Fe)9S8 → Fe2+ → Fe3+ → KFe3(SO4)2(OH)6 pathway; nickel experienced a transformation of (Ni,Fe)9S8 → NiS → Ni2+; sulfur modified through the pathway of S2−/S22− → Sn2− → S0 → SO32− → SO42−. During bioleaching, a sulfur-rich layer and jarosite layer formed on the mineral surface, and the rise of pH value accelerated the process. However, no evidence for the inhibition of the layers was shown in the bioleaching of pentlandite at pH 3.00. This study provides a novel method for the extraction of nickel from pentlandite by bioleaching at elevated pH values.
Open AccessMechanism for the Bio-Oxidation and Decomposition of Pentlandite: Implication for Nickel Bioleaching at Elevated pH
This work investigated the effects of Fe3+, H+ and adsorbed leaching bacteria on the bioleaching of pentlandite. Collectively, an integrated model for the oxidation and decomposition of pentlandite was built to describe the behaviors of different components in a bioleaching system. Proton ions and ferric ions could promote the break and oxidation of Ni-S and Fe-S bonds. The iron-oxidizing microorganisms could regenerate ferric ions and maintain a high Eh value. The sulfur-oxidizing microorganisms showed significant importance in the oxidation of polysulfide and elemental sulfur. The atoms in pentlandite show different modification pathways during the bioleaching process: iron transformed through a (Ni,Fe)9S8 → Fe2+ → Fe3+ → KFe3(SO4)2(OH)6 pathway; nickel experienced a transformation of (Ni,Fe)9S8 → NiS → Ni2+; sulfur modified through the pathway of S2−/S22− → Sn2− → S0 → SO32− → SO42−. During bioleaching, a sulfur-rich layer and jarosite layer formed on the mineral surface, and the rise of pH value accelerated the process. However, no evidence for the inhibition of the layers was shown in the bioleaching of pentlandite at pH 3.00. This study provides a novel method for the extraction of nickel from pentlandite by bioleaching at elevated pH values.
- 26 February 2019
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 119 (05) , 758-765
PD-1/PD-L Pathway Potentially Involved in ITP Immunopathogenesis
The binding of programmed death 1 (PD-1) to its ligands PD-L1 and PD-L2 on antigen-presenting cells turns off autoreactive T cells and induces peripheral tolerance. Aberrant PD-1/PD-L signalling could result in a breakdown of peripheral tolerance and lead to autoimmune diseases. In this study, we detected PD-1 and PD-L expression on T cells and dendritic cells (DCs) in immune thrombocytopaenia (ITP) patients with active disease by flow cytometry. The effects of PD-L1-Fc fusion protein (PD-L1-Fc) on T cells and on secretion of interferon-γ (IFN-γ) and interleukin-2 (IL-2) were detected by flow cytometry and enzyme-linked immunosorbent assay, respectively. Compared with healthy controls, PD-1 expression was significantly increased in CD4+ T cells and CD8+ T cells from patients with active ITP. However, PD-L1 expression on monocyte-derived DCs was lower in patients with active ITP than in healthy controls. In vitro assays revealed that PD-L1-Fc increased T cell apoptosis, inhibited activation and proliferation of CD4+ T cells and CD8+ T cells and decreased IFN-γ and IL-2 secretion in patients with active ITP. These results suggest that the aberrant PD-1/PD-L negative co-stimulatory pathway may play a role in ITP. Enhancing PD-1/PD-L signalling might be a promising therapeutic approach for ITP patients by enhancing T cell apoptosis, inhibiting T cell activation and proliferation and reducing secretion of inflammatory factors. M.N. and X.-x.L. performed research, analysed data and wrote the manuscript; Y.L., D.-d.Y., Q.L. and Y.H. performed research; Y.-n.M. and Q.F. performed research and analysed data; G.-s.L. and J.-z.S. analysed data; Y.S. contributed vital new reagents, designed the study and wrote the manuscript; M.H. revised the manuscript; and all authors read and edited the manuscript. Part of this study was orally presented at the 9th Congress of the Asian-Pacific Society on Thrombosis and Hemostasis, Taipei, Taiwan, China, October 6–9, 2016, and part of this study was presented as a poster at the 60th American Society of Hematology Annual Meeting, San Diego, California, United States, December 1–4, 2018. * M.N. and Y.L. contributed equally to this study.
- 26 February 2019
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 119 (05) , 758-765
PD-1/PD-L Pathway Potentially Involved in ITP Immunopathogenesis
The binding of programmed death 1 (PD-1) to its ligands PD-L1 and PD-L2 on antigen-presenting cells turns off autoreactive T cells and induces peripheral tolerance. Aberrant PD-1/PD-L signalling could result in a breakdown of peripheral tolerance and lead to autoimmune diseases. In this study, we detected PD-1 and PD-L expression on T cells and dendritic cells (DCs) in immune thrombocytopaenia (ITP) patients with active disease by flow cytometry. The effects of PD-L1-Fc fusion protein (PD-L1-Fc) on T cells and on secretion of interferon-γ (IFN-γ) and interleukin-2 (IL-2) were detected by flow cytometry and enzyme-linked immunosorbent assay, respectively. Compared with healthy controls, PD-1 expression was significantly increased in CD4+ T cells and CD8+ T cells from patients with active ITP. However, PD-L1 expression on monocyte-derived DCs was lower in patients with active ITP than in healthy controls. In vitro assays revealed that PD-L1-Fc increased T cell apoptosis, inhibited activation and proliferation of CD4+ T cells and CD8+ T cells and decreased IFN-γ and IL-2 secretion in patients with active ITP. These results suggest that the aberrant PD-1/PD-L negative co-stimulatory pathway may play a role in ITP. Enhancing PD-1/PD-L signalling might be a promising therapeutic approach for ITP patients by enhancing T cell apoptosis, inhibiting T cell activation and proliferation and reducing secretion of inflammatory factors. M.N. and X.-x.L. performed research, analysed data and wrote the manuscript; Y.L., D.-d.Y., Q.L. and Y.H. performed research; Y.-n.M. and Q.F. performed research and analysed data; G.-s.L. and J.-z.S. analysed data; Y.S. contributed vital new reagents, designed the study and wrote the manuscript; M.H. revised the manuscript; and all authors read and edited the manuscript. Part of this study was orally presented at the 9th Congress of the Asian-Pacific Society on Thrombosis and Hemostasis, Taipei, Taiwan, China, October 6–9, 2016, and part of this study was presented as a poster at the 60th American Society of Hematology Annual Meeting, San Diego, California, United States, December 1–4, 2018. * M.N. and Y.L. contributed equally to this study.